| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| G M Simpson, E H Pi, J J Srame. An update on tardive dyskinesia. Hospital & community psychiatry. vol 37. issue 4. 1986-06-09. PMID:2870977. |
supersensitivity of dopamine receptors is believed to be the cause of tardive dyskinesia, and treatment strategies have consisted of pharmacologic blockade of dopamine receptors, depletion of dopamine, and restoration of the balance between the dopaminergic system and the neurotransmitter systems that regulate it. |
1986-06-09 |
2023-08-11 |
Not clear |
| G M Goodwin, R J De Souza, A R Gree. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function. Neuropharmacology. vol 24. issue 12. 1986-04-07. PMID:2869435. |
the response was unaltered by a range of neurotransmitter antagonists: prazosin (alpha1-adrenoceptor), idazoxan (alpha2-adrenoceptor), metoprolol (beta1-adrenoceptor), erythro-dl-1-(7-methylindan-4-yloxy)-3-isopropylamino-but an-2-ol (beta2-adrenoceptor), (-)propranolol or (+/-)pindolol (beta-adrenoceptor), flupenthixol (dopamine) or ro 15-1788 (benzodiazepine binding site). |
1986-04-07 |
2023-08-11 |
mouse |
| H N Wagne. Quantitative imaging of neuroreceptors in the living human brain. Seminars in nuclear medicine. vol 16. issue 1. 1986-03-26. PMID:3003920. |
pet scans make it possible to assess the state of neurotransmitter receptors, such as the dopamine, serotonin, muscarinic cholinergic, opiate, and benzodiazepine receptors, in different regions in normal persons and patients with neuropsychiatric diseases. |
1986-03-26 |
2023-08-11 |
human |
| H A Nasrallah, F J Dunner, M McCalley-Whitters, R E Smit. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. The Journal of clinical psychiatry. vol 47. issue 2. 1986-03-14. PMID:3003037. |
one possible reason for this is that there have been no serious attempts to define the role of major neurotransmitter systems (dopamine, norepinephrine, acetylcholine, serotonin, gaba) in one specific population of tardive dyskinesia patients. |
1986-03-14 |
2023-08-11 |
Not clear |
| S Barasi, K N Dugga. The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat. European journal of pharmacology. vol 117. issue 3. 1986-02-17. PMID:3841070. |
dopamine (da) is thought to have a neurotransmitter role in the spinal cord of the rat. |
1986-02-17 |
2023-08-11 |
rat |
| J Z Nowa. Depolarisation-evoked release of dopamine and histamine from brain tissue and studies on presynaptic dopamine-histamine interaction. Polish journal of pharmacology and pharmacy. vol 37. issue 3. 1986-01-09. PMID:2866503. |
the inhibitory dopamine (da) presynaptic receptors which are localized on dopaminergic nerve terminals, so called da autoreceptors, modulate the neurotransmitter release and synthesis by means of negative feedback mechanism. |
1986-01-09 |
2023-08-11 |
rabbit |
| R J Stewart, M A Morency, R J Beninge. Differential effects of intrafrontocortical microinjections of dopamine agonists and antagonists on circling behavior of rats. Behavioural brain research. vol 17. issue 1. 1985-11-20. PMID:4041222. |
asymmetric posturing and circling behavior resulting from acute unilateral manipulation of central dopamine have been used to assess this neurotransmitter's contribution to motor control. |
1985-11-20 |
2023-08-11 |
rat |
| M Makino-Tasaka, T Suzuke, K Nagai, S Miyat. Spatial distribution of visual pigment and dopamine in the bullfrog retina. Experimental eye research. vol 40. issue 6. 1985-09-06. PMID:3874782. |
visual pigments and a neurotransmitter, dopamine, were quantitatively investigated in the retina of adult bullfrog, rana catesbeiana. |
1985-09-06 |
2023-08-11 |
Not clear |
| K Domańska-Janik, J Lazarewicz, K Noremberg, J Strosznajder, T Zalewsk. Metabolic disturbances of synaptosomes isolated from ischemic gerbil brain. Neurochemical research. vol 10. issue 5. 1985-08-22. PMID:2861577. |
the uptake of neurotransmitter substances, expressed as a percent of control value, was reduced 21% for norepinephrine, 40% for dopamine, 20% for choline, 24% for glutamate and 13% for gamma-aminobutyrate in ischemic synaptosomes. |
1985-08-22 |
2023-08-11 |
Not clear |
| C J Pycoc. Retinal neurotransmission. Survey of ophthalmology. vol 29. issue 5. 1985-06-14. PMID:2859657. |
the evidence for the proposal that the excitatory amino acids glutamate and aspartate are transmitters of photoreceptors, that gamma-aminobutyric acid (gaba) is the inhibitory transmitter of horizontal and amacrine cells, that acetylcholine is associated with the functioning of bipolar cells, and that taurine, glycine and dopamine may all also play neurotransmitter or neuromodulatory roles at amacrine cell synapses is discussed. |
1985-06-14 |
2023-08-11 |
Not clear |
| T B van Wimersma Greidanus, J Jolles, D De Wie. Hypothalamic neuropeptides and memory. Acta neurochirurgica. vol 75. issue 1-4. 1985-06-06. PMID:3993453. |
it is postulated that in case vasopressin affects retrieval processes the site of action is located in the amygdala and the dentate gyrus of the hippocampal complex with dopamine and serotonin as the respective neurotransmitter systems involved. |
1985-06-06 |
2023-08-11 |
rat |
| A N van den Po. Silver-intensified gold and peroxidase as dual ultrastructural immunolabels for pre- and postsynaptic neurotransmitters. Science (New York, N.Y.). vol 228. issue 4697. 1985-05-03. PMID:2858916. |
with this dual pre-embedding method, peroxidase-stained axons containing the inhibitory neurotransmitter gamma-aminobutyric acid were found to synapse directly on silver-stained dopamine neurons in the rat dorsomedial hypothalamus. |
1985-05-03 |
2023-08-11 |
rat |
| M R Bleavins, S J Bursian, J S Brewster, R J Auleric. Effects of dietary hexachlorobenzene exposure on regional brain biogenic amine concentrations in mink and European ferrets. Journal of toxicology and environmental health. vol 14. issue 2-3. 1984-12-31. PMID:6542146. |
the only change in regional brain dopamine (da) concentrations occurred at 500 ppm hcb in the midbrain of males, where there was a significant elevation of this neurotransmitter. |
1984-12-31 |
2023-08-12 |
Not clear |
| I Hanin, M R Krigman, R B Mailma. Central neurotransmitter effects of organotin compounds: trials, tribulations and observations. Neurotoxicology. vol 5. issue 2. 1984-12-26. PMID:6150454. |
by measuring the concentrations of dopamine, norepinephrine, homovanillic acid, dihydroxyphenylacetic acid, gamma-aminobutyric acid, acetylcholine, and choline in different brain areas of tmt and tet-treated animals, an attempt was made to correlate these functional deficits with changes in cns neurotransmitter alterations in vivo. |
1984-12-26 |
2023-08-12 |
rat |
| C van Valkenburg, J van der Krogt, P Moleman, H van Berkum, U Tjaden, J de Jon. A procedure to measure the specific activities of dopamine and its metabolites in rat striatum, based on HPLC, electrochemical detection and liquid scintillation counting. Journal of neuroscience methods. vol 11. issue 1. 1984-10-11. PMID:6471906. |
a procedure to determine the specific activities (s.a.) of the putative neurotransmitter dopamine (da) and its metabolites in rat striatum is described. |
1984-10-11 |
2023-08-12 |
rat |
| E D Bird, A H Anton, B Bulloc. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology. vol 5. issue 1. 1984-06-20. PMID:6538950. |
animals exposed to excessive mn develop neurological abnormalities, and neuropathological lesions in the brain mainly in the globus pallidus with decreased concentrations of the neurotransmitter, dopamine (da), in the brain. |
1984-06-20 |
2023-08-12 |
monkey |
| B Costall, A M Domeney, R J Naylo. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action. Psychopharmacology. vol 82. issue 3. 1984-05-30. PMID:6144126. |
acute injections of dopamine into the nucleus accumbens showed that the infusion of the different neurotransmitter substances caused change within that nucleus. |
1984-05-30 |
2023-08-12 |
human |
| O Hornykiewicz, S J Kis. Neurochemical basis of dementia in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 11. issue 1 Suppl. 1984-05-29. PMID:6143610. |
at present, the question whether the "cortical cholinergic deficiency" is the only (or sufficient) neurochemical basis for the cognitive impairment in parkinson patients with dementia cannot be answered with certainty; the additional role of other neurotransmitter changes known to occur in the parkinson brain, especially loss of cortical, hippocampal and subcortical noradrenaline and/or dopamine cannot be ruled out. |
1984-05-29 |
2023-08-12 |
Not clear |
| J M Lee, R F Ritzmann, J Z Field. Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas. Peptides. vol 5. issue 1. 1984-05-21. PMID:6231532. |
cyclo(leu-gly) (clg), a diketopiperazine analog of pro-leu-gly-nh2 (mif), affects a number of physiological and behavioral responses to the endogenous neurotransmitter, dopamine (da). |
1984-05-21 |
2023-08-12 |
Not clear |
| D van Heuven-Nolsen, E R De Kloet, D De Wied, D H Verstee. Microinjection of vasopressin and two related peptides into the amygdala: enhancing effect on local dopamine neurotransmission. Brain research. vol 293. issue 1. 1984-05-02. PMID:6142753. |
these effects of arg8-vasopressin, cyclo[lys-gly] and plg on dopamine utilization in the amygdala are correlated with those on avoidance behavior and can be interpreted as in support of the role of dopamine as neurotransmitter involved in retrieval processes. |
1984-05-02 |
2023-08-12 |
Not clear |